请输入您要查询的百科知识:

 

词条 Omegaven
释义

  1. References

  2. External links

Omegaven is a fatty acid emulsion produced by Fresenius Kabi. It is used for total parenteral nutrition (feeding directly into a venous catheter), e.g. in short bowel syndrome. It is rich in omega-3 fatty acids.

It has gained popularity in children in preference to the more commonly used Intralipid after case reports that it reduced the risk of liver damage.[1]

A recent study indicated that the use of Omegaven may be an appropriate intervention strategy for newborns with a very low birth weight, gastrochisis, and jejunal atresia.[2]

It is currently undergoing a clinical trial at National Taiwan University Hospital.[3]

Although the use of Omegaven in children in the United States is experimental, the use of it in adults in Europe is less controversial.[4] In European studies, Omegaven has been associated with a reduction in psoriasis, when contrasted to administration of omega-6 fatty acid Lipoven.[5] Omegaven has also been associated with reduced mortality and antibiotic use during hospital stays.[6]

Omegaven was approved for use in the United States on, July 27, 2018, and is now available to patients on the US market by prescription effective November 15, 2018.[7]

References

1. ^{{cite journal |vauthors=Gura KM, Duggan CP, Collier SB, etal |title=Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management |journal=Pediatrics |volume=118 |issue=1 |pages=e197–201 |year=2006 |pmid=16818533 |doi=10.1542/peds.2005-2662}}
2. ^{{cite journal |vauthors=Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK |title=Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease |journal=Journal of Perinatology |volume=27 |issue=5 |pages=284–90 |year=2007 |pmid=17344923 |doi=10.1038/sj.jp.7211686}}
3. ^{{ClinicalTrialsGov|NCT00172198}}
4. ^A Doctor's Push For Drug Pits Him Against Its Maker at Wall Street Journal
5. ^{{cite journal |vauthors=Mayser P, Grimm H, Grimminger F |title=n-3 fatty acids in psoriasis |series=87 |journal=Br. J. Nutr. |volume=Suppl 1 |issue= |pages=S77–82 |year=2002 |pmid=11895157 |doi=10.1079/bjn2001459}}
6. ^{{cite journal |vauthors=Heller AR, Rössler S, Litz RJ, etal |title=Omega-3 fatty acids improve the diagnosis-related clinical outcome |journal=Crit. Care Med. |volume=34 |issue=4 |pages=972–9 |year=2006 |pmid=16484909 |doi=10.1097/01.CCM.0000206309.83570.45}}
7. ^{{Cite web|url=https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/ucm368740.htm|title=Investigational New Drug (IND) Application - How to request Omegaven for Expanded Access Use|last=Research|first=Center for Drug Evaluation and|website=www.fda.gov|language=en|access-date=2019-02-15}}

External links

  • {{cite news |first=Robert |last=Cooke |title=How fish oil may have saved babies' lives |url=http://www.boston.com/news/globe/health_science/articles/2006/07/03/how_fish_oil_may_have_saved_babies_lives/ |work=The Boston Globe |date=2006-07-03 |accessdate=2007-08-22}}
  • "Fishing for the Right Solution" at Children's Hospital Boston
  • "The Right Kind of Oil" at Children's Hospital Boston
  • [https://www.thestar.com/Special/article/194260 Team on a Mission] at Toronto Star
  • Old Fashioned Lifeline Boston Globe 1/9/2009
  • rockcenter.nbcnews.com: drug treatment omegaven that could save infants lives not yet approved by fda
  • US approval in pediatric patients
  • [https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210589]

5 : Intensive care medicine|Hepatology|Gastroenterology|Pediatrics|Malnutrition

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/21 16:20:10